| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/18/2013 | WO2013053767A1 Treatment for rheumatoid arthritis |
| 04/18/2013 | WO2013053751A1 Compositions for the treatment of rheumatoid arthritis and methods of using same |
| 04/18/2013 | WO2013053741A1 Anti-spla2-v antibodies and uses thereof |
| 04/18/2013 | WO2013053694A1 Monoclonal anti-idiotype antibody ganglidiomab |
| 04/18/2013 | WO2013053021A1 ANTIBODIES TO CD1d |
| 04/18/2013 | WO2013028070A3 Compounds for use in boosting coagulation |
| 04/18/2013 | WO2013026452A9 Method for removing immunosuppresive properties of hiv envelope glycoproteins |
| 04/18/2013 | WO2013023043A3 Treatment of advanced solid tumors using combination of anti-erbb3 immunotherapy and selected chemotherapy |
| 04/18/2013 | WO2013017891A3 Assay |
| 04/18/2013 | WO2013006547A3 Antibodies against epidermal growth factor receptor (egfr) and uses thereof |
| 04/18/2013 | WO2013005194A3 Multispecific mutated antibody fab fragments |
| 04/18/2013 | US20130096283 Method of Supplementing Culture Media to Prevent Undesirable Amino Acid Substitutions |
| 04/18/2013 | US20130096282 Therapeutic antibodies against flagellated pseudomonas aeruginosa |
| 04/18/2013 | US20130096280 Methods and composition for secretion of heterologous polypeptides |
| 04/18/2013 | US20130096021 Recurrent gene fusions in breast cancer |
| 04/18/2013 | US20130095569 Pregnancy-associated plasma protein-a2 (papp-a2) polynucleotides |
| 04/18/2013 | US20130095551 Method for changing conformation of globular proteins |
| 04/18/2013 | US20130095549 Tweak receptor |
| 04/18/2013 | US20130095526 Anti-a(beta) oligomer humanized antibody |
| 04/18/2013 | US20130095498 Novel group b streptococcus antigens |
| 04/18/2013 | US20130095482 Methods of detecting pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/18/2013 | US20130095172 Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab |
| 04/18/2013 | US20130095123 New binder-drug conjugates (ADCs) and use thereof |
| 04/18/2013 | US20130095122 Peptides or Antibodies Which Bind to Melanoma Inhibitory Activity (MIA) Protein |
| 04/18/2013 | US20130095120 Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 04/18/2013 | US20130095116 RSPO Binding Agents and Uses Thereof |
| 04/18/2013 | US20130095115 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof |
| 04/18/2013 | US20130095114 T Cell Regulation |
| 04/18/2013 | US20130095113 Compositions and methods for treating neurological disorders |
| 04/18/2013 | US20130095111 Fusion proteins in cancer |
| 04/18/2013 | US20130095110 Hyaluronic Acid Decomposition-Promoting Factor and Inhibitor Thereof |
| 04/18/2013 | US20130095109 Antibody polypeptides that antagonize cd40l |
| 04/18/2013 | US20130095108 Factor xii inhibitors for treating interstitial lung disease |
| 04/18/2013 | US20130095107 Biomarker specific to brain/nerve or specific to neuronal differentiation |
| 04/18/2013 | US20130095106 Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites |
| 04/18/2013 | US20130095104 Anti-fzd10 monoclonal antibodies and methods for their use |
| 04/18/2013 | US20130095098 Pd-1 antibody |
| 04/18/2013 | US20130095097 Polypeptide Heterodimers and Uses Thereof |
| 04/18/2013 | US20130095096 Novel anti- alpha5beta1 antibodies and uses thereof |
| 04/18/2013 | US20130095093 Methods and compositions for treatment of immune dysfunction disorders |
| 04/18/2013 | US20130095069 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 04/18/2013 | US20130095034 Anti-CD74 Immunoconjugates and Methods |
| 04/18/2013 | DE112011102356T5 Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von Erkrankungen oder Zuständen, die mit dem Herz-Kreislauf-System in Verbindung stehen A pharmaceutical combination compositions and methods for treating diseases or conditions associated with the cardiovascular system |
| 04/18/2013 | DE112011102350T5 Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von Störungen des Urogenitalsystems A pharmaceutical combination composition and methods for treating disorders of the genitourinary |
| 04/18/2013 | DE112011102349T5 Pharmazeutische Zusammensetzung und Behandlungsverfahren The pharmaceutical composition and method of treatment |
| 04/18/2013 | DE102011054413A1 Monoklonaler anti-Idiotyp-Antikörper Ganglidiomab Monoclonal anti-idiotype antibody Ganglidiomab |
| 04/18/2013 | DE10149715B4 Esterase EstA aus Rhodococcus ruber Esterase from Rhodococcus ruber EstA |
| 04/18/2013 | CA2852099A1 Meditopes and meditope-binding antibodies and uses thereof |
| 04/18/2013 | CA2851987A1 Anti-spla2-v antibodies and uses thereof |
| 04/18/2013 | CA2851814A1 Antibody polypeptides that antagonize cd40l |
| 04/18/2013 | CA2851762A1 Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam) |
| 04/18/2013 | CA2851758A1 Canine/feline cd20 binding epitope and compositions for binding thereto |
| 04/18/2013 | CA2851751A1 Compositions for the treatment of rheumatoid arthritis and methods of using same |
| 04/18/2013 | CA2851534A1 A method for purifying antibodies |
| 04/18/2013 | CA2851322A1 Treatment for rheumatoid arthritis |
| 04/18/2013 | CA2850961A1 Antibodies to cd1d |
| 04/18/2013 | CA2850818A1 Improved assembly of bispecific antibodies |
| 04/18/2013 | CA2850032A1 Anti-htra1 antibodies and methods of use |
| 04/17/2013 | EP2581743A1 Method and reagent for detecting chronic liver disease by measurement of autotaxin |
| 04/17/2013 | EP2581388A1 Anti-sPLA2-V antibodies and uses thereof |
| 04/17/2013 | EP2581387A1 An anti-HIV-1 Tat monoclonal antibody |
| 04/17/2013 | EP2581113A1 Anti-tim-3 antibody |
| 04/17/2013 | EP2580243A1 Antibodies against human cd38 |
| 04/17/2013 | EP2580242A1 Modulation of the interaction between sorla and gdnf-family ligand receptors |
| 04/17/2013 | EP2580241A1 Annexin 1 antibody |
| 04/17/2013 | EP2580240A1 S100a4 antibodies and therapeutic uses thereof |
| 04/17/2013 | EP2580239A1 Treating cancer by modulating mammalian sterile 20-like kinase 3 |
| 04/17/2013 | EP2580238A1 Dimeric vstm3 fusion proteins and related compositions and methods |
| 04/17/2013 | EP2580232A1 Manipulation of hsp70 and ire1alpha protein interactions |
| 04/17/2013 | EP2579895A1 Anti-vegf antibodies and uses thereof |
| 04/17/2013 | EP2579894A1 Cgrp antibodies |
| 04/17/2013 | CN103052649A Antibodies with modified isoelectric points |
| 04/17/2013 | CN103048451A Colloidal gold immunization test strip and detection method for detecting plum pox virus |
| 04/17/2013 | CN103045635A Expression process of coat protein gene of prunus necrotic ring spot virus (PNRSV), antiserum and kit |
| 04/17/2013 | CN103045607A Preparation method of completely humanized antibody of infectious disease pathogen |
| 04/17/2013 | CN103045542A Monoclonal anti-soybean lipoxygenase Lox2 antibody hybridoma cell strain and antibody and application thereof |
| 04/17/2013 | CN103045541A Hybridoma cell strain and monoclonal antibody of anti-heart-type fatty acid-binding protein generated by same |
| 04/17/2013 | CN103044553A Double-specificity monoclonal antibody resistant to triazophos and chlorpyrifos and preparation method and application thereof |
| 04/17/2013 | CN103044552A Humanized monoclonal antibody for resisting DEC-205 molecules on surface of dendritic cells |
| 04/17/2013 | CN103044551A Monoclonal antibody for preventing and treating spontaneous abortion and application thereof |
| 04/17/2013 | CN103044550A IL-31 monoclonal antibodies and methods of use |
| 04/17/2013 | CN103044549A Preparation method of apis cerana antimicrobial peptide AccRoyalisin polyclonal antibody and use thereof |
| 04/17/2013 | CN103044548A Specific autoantibody of PBC (primary biliary cirrhosis) and application |
| 04/17/2013 | CN103044547A Anti-humanized multidrug resistant protein Fab antibody and preparation method thereof |
| 04/17/2013 | CN103044546A Prion protein antibody as well as preparation method and application thereof |
| 04/17/2013 | CN103044545A Vibrio vulnificus flagellin monoclonal antibody and antigen capture ELISA (Enzyme Linked Immunosorbent Assay) kit |
| 04/17/2013 | CN103044544A ELISA (enzyme-linked immunosorbent assay) kit for detecting highly pathogenic PRRSV (porcine reproductive and respiratory syndrome virus) and application thereof |
| 04/17/2013 | CN103044543A Production method and application of immune globulin G |
| 04/17/2013 | CN103044537A CFTR recombinant protein, its encoding gene and use |
| 04/17/2013 | CN103044528A Strawberry vein banding virus antibody, and antigen polypeptide, immunogen and application thereof |
| 04/17/2013 | CN103040732A Immunoglobulin formulation and method of preparation thereof |
| 04/17/2013 | CN102747042B Hybridoma cell line 10G4 and anti-alfatoxin total (B1, B2, G1 and G2) monoclonal antibody produced by the same |
| 04/17/2013 | CN102250239B Protein capable of combining with vp60 protein of rabbit hemorrhagic disease virus and use thereof |
| 04/17/2013 | CN102206278B Monoclonal antibody of anti-LCDV (lymphocystis disease virus) 27.8kDa receptor protein and preparation method thereof |
| 04/17/2013 | CN102199210B Anti-interleukin-8 antibody |
| 04/17/2013 | CN102199209B Anti-interleukin-8 antibody |
| 04/17/2013 | CN101687021B Uses of monoclonal antibody 8H9 |
| 04/17/2013 | CN101466732B Collagen type IV-like immunoreactive peptide |
| 04/17/2013 | CN101433715B Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/17/2013 | CN101365487B Method for treating joint damage |